Exact Mass: 246.13847379999999

Exact Mass Matches: 246.13847379999999

Found 133 metabolites which its exact mass value is equals to given mass value 246.13847379999999, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

L-Tryptophan betaine

(2S)-3-(1H-indol-3-yl)-2-(trimethylazaniumyl)propanoate

C14H18N2O2 (246.1368208)


Hypaphorine is an amino acid betaine obtaine by exhaustive methylation of the alpha-amino group of L-tryptophan with concomitant deprotonation of the carboxy group. It has a role as a plant metabolite, a xenobiotic and a fungal metabolite. It is an amino-acid betaine, a L-tryptophan derivative and an indole alkaloid. Hypaphorine is a natural product found in Erythrina suberosa, Erythrina subumbrans, and other organisms with data available. Lenticin or hypaphorine is a compound found in lentil extracts. It can also be detected in blood after an individual has consumed lentils and may therefore serve as a food biomarker. Lenticin is an indole alkaloid that is essentially an N-methylated form of tryptophan. It is known to be a sleep-inducing compound (PMID: 18571406). In plants it is an agonist of the plant hormone indole acetic acid. An amino acid betaine obtaine by exhaustive methylation of the alpha-amino group of L-tryptophan with concomitant deprotonation of the carboxy group. (+)-Hypaphorine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=487-58-1 (retrieved 2024-07-01) (CAS RN: 487-58-1). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Hypaphorine is an indole alkaloid isolated from Caragana korshinskii, and with neurological and glucose-lowering effects in rodents[1]. Hypaphorine is an indole alkaloid isolated from Caragana korshinskii, and with neurological and glucose-lowering effects in rodents[1].

   

Octopine

N2-(D-1-Carboxyethyl)-L-arginine

C9H18N4O4 (246.1327988)


The (1R)-1-carboxyethyl derivative of L-arginine. It is a metabolite released by plant tumours. KEIO_ID O009; [MS2] KO009138 KEIO_ID O009

   

2-Deoxystreptidine

2-Deoxystreptidine; N,N-Bis(aminoiminomethyl)-2-deoxy-streptamine

C8H18N6O3 (246.14403180000002)


   

N2-(Carboxyethyl)-L-arginine

N2-(2-Carboxyethyl)-L-arginine

C9H18N4O4 (246.1327988)


   

3-Hydroxydodecanedioic acid

3-HYDROXYDODECANEDIOIC ACID

C12H22O5 (246.14671620000001)


3-Hydroxydecanedioic acid appears in the urine of children affected with peroxisomal disorders. Peroxisomal biogenesis disorders (PBDs) are characterized by generalized peroxisomal dysfunction due to defective assembly of the organelle and include the Zellweger, neonatal adrenoleukodystrophy and infantile Refsum phenotypes (PMID 10896310) [HMDB] 3-Hydroxydecanedioic acid appears in the urine of children affected with peroxisomal disorders. Peroxisomal biogenesis disorders (PBDs) are characterized by generalized peroxisomal dysfunction due to defective assembly of the organelle and include the Zellweger, neonatal adrenoleukodystrophy and infantile Refsum phenotypes (PMID 10896310).

   

Dibutyl malate

Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, dibutyl ester

C12H22O5 (246.14671620000001)


Dibutyl malate is found in fruits. Dibutyl malate is isolated from tamarind fruits (Tamarindus indica

   

Nefiracetam

N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)ethanimidic acid

C14H18N2O2 (246.1368208)


D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs D002491 - Central Nervous System Agents > D018697 - Nootropic Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents Nefiracetam is a GABAergic, cholinergic, and monoaminergic neuronal systems enhancer for Ro 5-4864-induced convulsions. Target: GABA Receptor Nefiracetam induces a short-term depression of ACh-evoked currents at submicromolar concentrations (0.01-0.1 μM) and a long-term enhancement of the currents at micromolar concentrations (1-10 μM). Nefiracetam interacts with PKA and PKC pathways, which may explain a cellular mechanism for the action of cognition-enhancing agents. Lower (submicromolar) concentrations of the nootropic Nefiracetam reduces ACh-evoked currents to 30\% (0.01 μM) and 38\% (0.1 μM) of control after a 10-minute treatment [1]. Nefiracetam administered orally inhibits Ro 5-4864-induced convulsions in EL mice. Nefiracetam also efficiently inhibits Ro 5-4864-induced convulsions in DDY mice at doses higher than 10 mg/kg [2]. Nefiracetam administered daily 1 hour before each training session facilitates the acquisition process of the avoidance response [3].

   

Octopine

5-carbamimidamido-2-[(1-carboxyethyl)amino]pentanoic acid

C9H18N4O4 (246.1327988)


   

Parsalmide

5-amino-N-butyl-2-(prop-2-yn-1-yloxy)benzamide

C14H18N2O2 (246.1368208)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

(2S)-2-(Carboxymethylamino)-5-(diaminomethylideneamino)-4-methylpentanoic acid

(2S)-2-(Carboxymethylamino)-5-(diaminomethylideneamino)-4-methylpentanoic acid

C9H18N4O4 (246.1327988)


   

(E,E,E)-1,7-diphenyl-1,3,5-heptatriene|1,7-diphenylhepta-1,3,5-triene

(E,E,E)-1,7-diphenyl-1,3,5-heptatriene|1,7-diphenylhepta-1,3,5-triene

C19H18 (246.1408428)


   
   
   
   

(E)-N-(3-acetamidopropyl)-cinnamamide

(E)-N-(3-acetamidopropyl)-cinnamamide

C14H18N2O2 (246.1368208)


   
   
   
   

12-alpha-hydroxycamoensine

12-alpha-hydroxycamoensine

C14H18N2O2 (246.1368208)


   

Nefiracetam

Nefiracetam (Translon)

C14H18N2O2 (246.1368208)


D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs D002491 - Central Nervous System Agents > D018697 - Nootropic Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents Nefiracetam is a GABAergic, cholinergic, and monoaminergic neuronal systems enhancer for Ro 5-4864-induced convulsions. Target: GABA Receptor Nefiracetam induces a short-term depression of ACh-evoked currents at submicromolar concentrations (0.01-0.1 μM) and a long-term enhancement of the currents at micromolar concentrations (1-10 μM). Nefiracetam interacts with PKA and PKC pathways, which may explain a cellular mechanism for the action of cognition-enhancing agents. Lower (submicromolar) concentrations of the nootropic Nefiracetam reduces ACh-evoked currents to 30\% (0.01 μM) and 38\% (0.1 μM) of control after a 10-minute treatment [1]. Nefiracetam administered orally inhibits Ro 5-4864-induced convulsions in EL mice. Nefiracetam also efficiently inhibits Ro 5-4864-induced convulsions in DDY mice at doses higher than 10 mg/kg [2]. Nefiracetam administered daily 1 hour before each training session facilitates the acquisition process of the avoidance response [3].

   
   

Tryptophan betaine

Tryptophan betaine

C14H18N2O2 (246.1368208)


MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; AOHCBEAZXHZMOR-ZDUSSCGKSA-N_STSL_0038_Tryptophan betaine_0500fmol_180407_S2_LC02_MS02_09; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I.

   
   
   
   
   

Dibutyl malate

Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, dibutyl ester

C12H22O5 (246.14671620000001)


   

FA 12:1;O3

3-hydroxy-dodecanedioic acid

C12H22O5 (246.14671620000001)


   

ascr#2

(-)-5R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2???-yloxy)-2-hexanone

C12H22O5 (246.14671620000001)


A hydroxy ketone ascaroside obtained by formal condensation of the hydroxy group of (5R)-5-hydroxyhexan-2-one with ascarylopyranose (the alpha anomer). It is a major component of the dauer pheromone, used by the nematode Caenorhabditis elegans as a population-density signal to promote entry into an alternate larval stage, the nonfeeding and highly persistent dauer diapause, and also synergises with ascr#3, ascr#4, and ascr#8 in male attraction. Ascr#2 is an ascaroside isolated from Caenorhabditis elegans, potently promotes dauer formation, and also acts as a potent male attractant combined with ascr#3 at low concentration[1].

   

4,7-DIAZA-SPIRO[2.5]OCTANE-4-CARBOXYLIC ACID BENZYL ESTER

4,7-DIAZA-SPIRO[2.5]OCTANE-4-CARBOXYLIC ACID BENZYL ESTER

C14H18N2O2 (246.1368208)


   

TERT-BUTYL 4-CYANOPHENETHYLCARBAMATE

TERT-BUTYL 4-CYANOPHENETHYLCARBAMATE

C14H18N2O2 (246.1368208)


   

3-AMINOMETHYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-AMINOMETHYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C14H18N2O2 (246.1368208)


   

Methyl 4-amino-1-benzyl-1,2,5,6-tetrahydropyridine-3-carboxylate

Methyl 4-amino-1-benzyl-1,2,5,6-tetrahydropyridine-3-carboxylate

C14H18N2O2 (246.1368208)


   

4-Acetylphenylboronic acid pinacol ester

4-Acetylphenylboronic acid pinacol ester

C14H19BO3 (246.1427174)


   

2,2-(((OXYBIS(PROPANE-2,1-DIYL))BIS(OXY))BIS(METHYLENE))BIS(OXIRANE)

2,2-(((OXYBIS(PROPANE-2,1-DIYL))BIS(OXY))BIS(METHYLENE))BIS(OXIRANE)

C12H22O5 (246.14671620000001)


   

L-4-METHYLPHENYLALANINE

L-4-METHYLPHENYLALANINE

C14H18N2O2 (246.1368208)


   

4-Acetoxy-N,N-dimethyltryptamine

4-Acetoxy-N,N-dimethyltryptamine

C14H18N2O2 (246.1368208)


   

Diethyl 3,3-dimethylcyclohex-1-enylphosphonate

Diethyl 3,3-dimethylcyclohex-1-enylphosphonate

C12H23O3P (246.13847379999999)


   

(S)-N-Cbz-Leucinenitrile

(S)-N-Cbz-Leucinenitrile

C14H18N2O2 (246.1368208)


   

1,3-Dihydroisobenzofuran-5-boronic acid pinacol ester

1,3-Dihydroisobenzofuran-5-boronic acid pinacol ester

C14H19BO3 (246.1427174)


   

2-(3,4 epoxycyclohexyl)ethyltrimethoxysilane

2-(3,4 epoxycyclohexyl)ethyltrimethoxysilane

C11H22O4Si (246.1287292)


   

2-[(4-methoxyphenyl)methyl]-5-propyl-4H-pyrazol-3-one

2-[(4-methoxyphenyl)methyl]-5-propyl-4H-pyrazol-3-one

C14H18N2O2 (246.1368208)


   

tert-butyl [(1r)-1-cyano-2-phenylethyl]carbamate

tert-butyl [(1r)-1-cyano-2-phenylethyl]carbamate

C14H18N2O2 (246.1368208)


   

6-AMINOMETHYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

6-AMINOMETHYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C14H18N2O2 (246.1368208)


   

cis-2-Cbz-hexahydropyrrolo[3,4-c]pyrrole

cis-2-Cbz-hexahydropyrrolo[3,4-c]pyrrole

C14H18N2O2 (246.1368208)


   

6-Methyl-4-phenyl-1,2,3,5-tetrahydro-s-indacene

6-Methyl-4-phenyl-1,2,3,5-tetrahydro-s-indacene

C19H18 (246.1408428)


   

2-N-Boc-amino-1-Methyl indole

2-N-Boc-amino-1-Methyl indole

C14H18N2O2 (246.1368208)


   

2-(3,3-DIMETHYL-3,4-DIHYDRO-ISOQUINOLIN-1-YL-AMINO)-PROPIONIC ACID

2-(3,3-DIMETHYL-3,4-DIHYDRO-ISOQUINOLIN-1-YL-AMINO)-PROPIONIC ACID

C14H18N2O2 (246.1368208)


   

(1S,6R)-8-Cbz-3,8-diazabicyclo[4.2.0]octane

(1S,6R)-8-Cbz-3,8-diazabicyclo[4.2.0]octane

C14H18N2O2 (246.1368208)


   
   

(S)-N-Boc-phenylalaninenitrile

(S)-N-Boc-phenylalaninenitrile

C14H18N2O2 (246.1368208)


   

benzyl 1,7-diazaspiro[3.4]octane-1-carboxylate

benzyl 1,7-diazaspiro[3.4]octane-1-carboxylate

C14H18N2O2 (246.1368208)


   

1,6-Diazaspiro[3.4]octane-6-carboxylic acid, phenylmethyl ester

1,6-Diazaspiro[3.4]octane-6-carboxylic acid, phenylmethyl ester

C14H18N2O2 (246.1368208)


   

Benzyl 2,5-diazaspiro[3.4]octane-5-carboxylate

Benzyl 2,5-diazaspiro[3.4]octane-5-carboxylate

C14H18N2O2 (246.1368208)


   

6-(PIPERIDIN-4-YLMETHYL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE

6-(PIPERIDIN-4-YLMETHYL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE

C14H18N2O2 (246.1368208)


   

tert-Butyl ((1H-indol-5-yl)methyl)carbamate

tert-Butyl ((1H-indol-5-yl)methyl)carbamate

C14H18N2O2 (246.1368208)


   
   

2-(2-diethylaminoethyl)-1H-isoindole-1,3(2H)-dione

2-(2-diethylaminoethyl)-1H-isoindole-1,3(2H)-dione

C14H18N2O2 (246.1368208)


   

2-(1-adamantyl)-6-amino-1H-1,3,5-triazin-4-one

2-(1-adamantyl)-6-amino-1H-1,3,5-triazin-4-one

C13H18N4O (246.14805379999999)


   

1-[(1-Hydroperoxycyclohexyl)peroxy]cyclohexanol

1-[(1-Hydroperoxycyclohexyl)peroxy]cyclohexanol

C12H22O5 (246.14671620000001)


   

ethyl 6-methyl-2-propan-2-ylimidazo[1,2-a]pyridine-3-carboxylate

ethyl 6-methyl-2-propan-2-ylimidazo[1,2-a]pyridine-3-carboxylate

C14H18N2O2 (246.1368208)


   

Benzyl 4,7-diazaspiro[2.5]octane-7-carboxylate

Benzyl 4,7-diazaspiro[2.5]octane-7-carboxylate

C14H18N2O2 (246.1368208)


   

5-[1-Hydroxy-2-(isopropylamino)ethyl]-8-quinolinol

5-[1-Hydroxy-2-(isopropylamino)ethyl]-8-quinolinol

C14H18N2O2 (246.1368208)


   

DM 235

DM 235

C14H18N2O2 (246.1368208)


Sunifiram (DM-235) is an ampakine-like compound with better nootropic activity than piracetam.

   

3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde

3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde

C14H19BO3 (246.1427174)


   

N-(4-(PIPERIDINE-4-CARBONYL)PHENYL)ACETAMIDE

N-(4-(PIPERIDINE-4-CARBONYL)PHENYL)ACETAMIDE

C14H18N2O2 (246.1368208)


   

3-(3,3-DIMETHYL-3,4-DIHYDRO-ISOQUINOLIN-1-YLAMINO)-PROPIONIC ACID

3-(3,3-DIMETHYL-3,4-DIHYDRO-ISOQUINOLIN-1-YLAMINO)-PROPIONIC ACID

C14H18N2O2 (246.1368208)


   

BIS(ETHYLMETHYLKETOXIME)METHOXYMETHYLSILANE

BIS(ETHYLMETHYLKETOXIME)METHOXYMETHYLSILANE

C10H22N2O3Si (246.1399622)


   

3-((2-hydroxyethylamino)methyl)-6,8-dimethylquinolin-2(1H)-one

3-((2-hydroxyethylamino)methyl)-6,8-dimethylquinolin-2(1H)-one

C14H18N2O2 (246.1368208)


   

(R)-1-BENZYL-3-ISOPROPYLPIPERAZINE-2,5-DIONE

(R)-1-BENZYL-3-ISOPROPYLPIPERAZINE-2,5-DIONE

C14H18N2O2 (246.1368208)


   

tert-Butyl ((1H-indol-3-yl)methyl)carbamate

tert-Butyl ((1H-indol-3-yl)methyl)carbamate

C14H18N2O2 (246.1368208)


   

2-(2,3-Dihydrobenzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(2,3-Dihydrobenzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C14H19BO3 (246.1427174)


   

2-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde

2-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde

C14H19BO3 (246.1427174)


   

2-[2-(2-ethoxyethoxy)ethoxy]ethyl methacrylate

2-[2-(2-ethoxyethoxy)ethoxy]ethyl methacrylate

C12H22O5 (246.14671620000001)


   

1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ETHANONE

1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ETHANONE

C14H19BO3 (246.1427174)


   

3-methyl-N-cyanoethyl-N-acetoxyethylaniline

3-methyl-N-cyanoethyl-N-acetoxyethylaniline

C14H18N2O2 (246.1368208)


   

2-(2,3-Dihydrobenzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(2,3-Dihydrobenzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C14H19BO3 (246.1427174)


   

1-[2-(DIETHYLAMINO)ETHYL]-1H-INDOLE-2,3-DIONE

1-[2-(DIETHYLAMINO)ETHYL]-1H-INDOLE-2,3-DIONE

C14H18N2O2 (246.1368208)


   

trimethyl-(3-methyl-1-trimethylsilyloxybut-1-enoxy)silane

trimethyl-(3-methyl-1-trimethylsilyloxybut-1-enoxy)silane

C11H26O2Si2 (246.1471256)


   

4-AMINOMETHYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-AMINOMETHYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C14H18N2O2 (246.1368208)


   

ETHYL 3-(6-PYRROLIDIN-1-YLPYRIDIN-3-YL)ACRYLATE

ETHYL 3-(6-PYRROLIDIN-1-YLPYRIDIN-3-YL)ACRYLATE

C14H18N2O2 (246.1368208)


   

(1-(4-MORPHOLINYL)PROPYL)BENZOTRIAZOLE

(1-(4-MORPHOLINYL)PROPYL)BENZOTRIAZOLE

C13H18N4O (246.14805379999999)


   

8-Benzyl-1-oxa-3,8-diazaspiro[4.5]decan-2-one

8-Benzyl-1-oxa-3,8-diazaspiro[4.5]decan-2-one

C14H18N2O2 (246.1368208)


   

1-Amino-6-cyclohex-3-enylmethyloxypurine

1-Amino-6-cyclohex-3-enylmethyloxypurine

C13H18N4O (246.14805379999999)


   

3-(1H-indol-3-yl)-2-(trimethylazaniumyl)propanoate

3-(1H-indol-3-yl)-2-(trimethylazaniumyl)propanoate

C14H18N2O2 (246.1368208)


   

N,N-(4-Xylylidene)bisaminoguanidine

N,N-(4-Xylylidene)bisaminoguanidine

C10H14N8 (246.1341364)


   

3-[(Dimethylamino)methyl]-4-[methyl(phenyl)amino]furan-2(5H)-one

3-[(Dimethylamino)methyl]-4-[methyl(phenyl)amino]furan-2(5H)-one

C14H18N2O2 (246.1368208)


   

L-Arginine, N2-[(1R)-1-carboxyethyl]-

L-Arginine, N2-[(1R)-1-carboxyethyl]-

C9H18N4O4 (246.1327988)


   

(2S)-2-(Carboxymethylamino)-5-(diaminomethylideneamino)-4-methylpentanoic acid

(2S)-2-(Carboxymethylamino)-5-(diaminomethylideneamino)-4-methylpentanoic acid

C9H18N4O4 (246.1327988)


   

[3-Carboxy-2-(3-oxobutanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3-oxobutanoyloxy)propyl]-trimethylazanium

C11H20NO5+ (246.134141)


   

N-butyl-5-methoxy-1H-indole-2-carboxamide

N-butyl-5-methoxy-1H-indole-2-carboxamide

C14H18N2O2 (246.1368208)


   

N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]butanamide

N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]butanamide

C14H18N2O2 (246.1368208)


   

(2S)-5-{[amino(iminio)methyl]amino}-2-[(2-carboxylatoethyl)azaniumyl]pentanoate

(2S)-5-{[amino(iminio)methyl]amino}-2-[(2-carboxylatoethyl)azaniumyl]pentanoate

C9H18N4O4 (246.1327988)


   

N-(cyclopentylideneamino)-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide

N-(cyclopentylideneamino)-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide

C13H18N4O (246.14805379999999)


   

(5Z)-2,2-dimethyl-5-[2-(4-methylphenyl)hydrazinylidene]tetrahydro-4H-pyran-4-one

(5Z)-2,2-dimethyl-5-[2-(4-methylphenyl)hydrazinylidene]tetrahydro-4H-pyran-4-one

C14H18N2O2 (246.1368208)


   

[(2R)-3-carboxy-2-(3-oxobutanoyloxy)propyl]-trimethylazanium

[(2R)-3-carboxy-2-(3-oxobutanoyloxy)propyl]-trimethylazanium

C11H20NO5+ (246.134141)


   

N2-(1-Carboxyethyl)-L-arginine

N2-(1-Carboxyethyl)-L-arginine

C9H18N4O4 (246.1327988)


   

Valylglycine, TMS derivative

Valylglycine, TMS derivative

C10H22N2O3Si (246.1399622)


   

Glycyl-L-Valine, TMS derivative

Glycyl-L-Valine, TMS derivative

C10H22N2O3Si (246.1399622)


   

Heptanedioic acid, methyl trimethylsilyl ester

Heptanedioic acid, methyl trimethylsilyl ester

C11H22O4Si (246.1287292)


   

4,4-Dimethyl mono-methylglutarate, trimethylsilyl ester

4,4-Dimethyl mono-methylglutarate, trimethylsilyl ester

C11H22O4Si (246.1287292)


   

4-Trimethylsilylmethyl-6-phenyl-5,6-dihydro-2H-pyran

4-Trimethylsilylmethyl-6-phenyl-5,6-dihydro-2H-pyran

C15H22OSi (246.14398419999998)


   

Methyl 3-oxo-5-trimethylsilylethoxypentanoate

Methyl 3-oxo-5-trimethylsilylethoxypentanoate

C11H22O4Si (246.1287292)


   

(Z)-3-Methyl-5-oxo-5-phenyl-2-pentenyltrimethylsilane

(Z)-3-Methyl-5-oxo-5-phenyl-2-pentenyltrimethylsilane

C15H22OSi (246.14398419999998)


   

3-Methylene-5-phenyl-5-trimethylsilyloxy-1-pentene

3-Methylene-5-phenyl-5-trimethylsilyloxy-1-pentene

C15H22OSi (246.14398419999998)


   

(1-Acetyloxy-3-hydroxypropan-2-yl) heptanoate

(1-Acetyloxy-3-hydroxypropan-2-yl) heptanoate

C12H22O5 (246.14671620000001)


   

(1-Hydroxy-3-propanoyloxypropan-2-yl) hexanoate

(1-Hydroxy-3-propanoyloxypropan-2-yl) hexanoate

C12H22O5 (246.14671620000001)


   

(1-Butanoyloxy-3-hydroxypropan-2-yl) pentanoate

(1-Butanoyloxy-3-hydroxypropan-2-yl) pentanoate

C12H22O5 (246.14671620000001)


   

N2-(D-1-Carboxyethyl)-L-arginine

N2-(D-1-Carboxyethyl)-L-arginine

C9H18N4O4 (246.1327988)


   

N2-(Carboxyethyl)-L-arginine

N2-(Carboxyethyl)-L-arginine

C9H18N4O4 (246.1327988)


   

D-octopine dizwitterion

D-octopine dizwitterion

C9H18N4O4 (246.1327988)


A D-alpha-amino acid zwitterion that is D-octopine in which both carboxy groups are anionic and the secondary amino and guanidine imino functions are protonated.

   

Parsalmide

Parsalmide

C14H18N2O2 (246.1368208)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

ascaroside C6

ascaroside C6

C12H22O5 (246.14671620000001)


Ascr#2 is an ascaroside isolated from Caenorhabditis elegans, potently promotes dauer formation, and also acts as a potent male attractant combined with ascr#3 at low concentration[1].

   

N(2)-(2-carboxyethyl)-L-arginine dizwitterion

N(2)-(2-carboxyethyl)-L-arginine dizwitterion

C9H18N4O4 (246.1327988)


An amino acid zwitterion obtained from N(2)-(2-carboxyethyl)-L-arginine by the removal of a proton for both of the carboxy groups and the addition of a proton to the alpha-amino group and to the guanidyl group.

   
   
   
   

Cyclo(L-Phe-L-Val)

Cyclo(L-Phe-L-Val)

C14H18N2O2 (246.1368208)


Cyclo(L-Phe-L-Val) is a potent inhibitor of enzymes isocitrate lyase (ICL) (IC50=27 μg/mL). cyclo(L-Phe-L-Val) inhibits the gene transcription of ICL in C. albicans under C2-carbon-utilizing conditions[1].

   

n-(5,7a-dimethyl-1-oxo-5h-pyrrolizin-3-yl)-3-methylbut-2-enamide

n-(5,7a-dimethyl-1-oxo-5h-pyrrolizin-3-yl)-3-methylbut-2-enamide

C14H18N2O2 (246.1368208)


   

[(5e)-7-phenylhepta-1,3,5-trien-1-yl]benzene

[(5e)-7-phenylhepta-1,3,5-trien-1-yl]benzene

C19H18 (246.1408428)


   

11-hydroxy-7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadeca-2,4-dien-6-one

11-hydroxy-7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadeca-2,4-dien-6-one

C14H18N2O2 (246.1368208)


   

[(1e,3e,5e)-7-phenylhepta-1,3,5-trien-1-yl]benzene

[(1e,3e,5e)-7-phenylhepta-1,3,5-trien-1-yl]benzene

C19H18 (246.1408428)


   

n-[(5s,7as)-5,7a-dimethyl-1-oxo-5h-pyrrolizin-3-yl]-3-methylbut-2-enamide

n-[(5s,7as)-5,7a-dimethyl-1-oxo-5h-pyrrolizin-3-yl]-3-methylbut-2-enamide

C14H18N2O2 (246.1368208)


   

methyl 2-(dimethylamino)-3-(1h-indol-3-yl)propanoate

methyl 2-(dimethylamino)-3-(1h-indol-3-yl)propanoate

C14H18N2O2 (246.1368208)


   

(7-phenylhepta-1,3,5-trien-1-yl)benzene

(7-phenylhepta-1,3,5-trien-1-yl)benzene

C19H18 (246.1408428)


   

3-benzyl-6-isopropyl-3,6-dihydropyrazine-2,5-diol

3-benzyl-6-isopropyl-3,6-dihydropyrazine-2,5-diol

C14H18N2O2 (246.1368208)


   

methyl (2s)-2-(dimethylamino)-3-(1h-indol-3-yl)propanoate

methyl (2s)-2-(dimethylamino)-3-(1h-indol-3-yl)propanoate

C14H18N2O2 (246.1368208)


   

(2s)-2-amino-3-(1h-indol-3-yl)-2,3-dimethylbutanoic acid

(2s)-2-amino-3-(1h-indol-3-yl)-2,3-dimethylbutanoic acid

C14H18N2O2 (246.1368208)


   

(1r,9r,10s,11s)-11-hydroxy-7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadeca-2,4-dien-6-one

(1r,9r,10s,11s)-11-hydroxy-7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadeca-2,4-dien-6-one

C14H18N2O2 (246.1368208)


   

(2s,3r,4r,5r,6s)-2-[(3z)-hex-3-en-1-yloxy]-6-methyloxane-3,4,5-triol

(2s,3r,4r,5r,6s)-2-[(3z)-hex-3-en-1-yloxy]-6-methyloxane-3,4,5-triol

C12H22O5 (246.14671620000001)


   

(2r,3r,4s,5s,6r)-2-[(3z)-hex-3-en-1-yloxy]-6-methyloxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-[(3z)-hex-3-en-1-yloxy]-6-methyloxane-3,4,5-triol

C12H22O5 (246.14671620000001)


   

2-(hex-3-en-1-yloxy)-6-methyloxane-3,4,5-triol

2-(hex-3-en-1-yloxy)-6-methyloxane-3,4,5-triol

C12H22O5 (246.14671620000001)


   

(3s,6s)-3-benzyl-6-isopropyl-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-benzyl-6-isopropyl-3,6-dihydropyrazine-2,5-diol

C14H18N2O2 (246.1368208)